Alkem Laboratories informs about press release

15 Mar 2021 Evaluate

Alkem Laboratories has informed that Company has launched Brivaracetam in India under the brand name ‘Brivasure’, an affordable anti-epileptic drug for the treatment of Epilepsy in India. Brivasure has received authorization from the Drug Controller General of India (DCGI). In this regard, the company has enclosed a press release on 15th March 2021 titled ‘Alkem makes epilepsy treatment more accessible & affordable with the launch of Brivasure (Brivaracetam)’.

The above information is a part of company’s filings submitted to BSE.

Alkem Laboratories Share Price

5689.30 77.65 (1.38%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×